In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| 10-K | 10-K | 10-K | 10-K |
Revenues: |
Germany | | | 1.1 | |
United States | | | 31.1 | |
Other | | | 7.4 | |
Total revenues | 0.3 | 3.0 | 39.6 | 18.0 |
Revenue growth | -90.0% | -92.4% | 119.8% | |
Cost of goods sold | 51.5 | 36.7 | 15.4 | 6.8 |
Gross profit | -51.2 | -33.7 | 24.2 | 11.2 |
Gross margin | -17078.7% | -1122.4% | 61.1% | 62.2% |
Selling, general and administrative [+] | 78.2 | 87.1 | 63.6 | 55.7 |
Sales and marketing | 40.7 | 52.2 | 42.2 | 41.6 |
General and administrative | 37.5 | 34.9 | 21.4 | 14.0 |
Other operating expenses | -77.7 | -68.3 | -0.6 | |
EBITDA [+] | -11.7 | -24.0 | -38.4 | -44.3 |
EBITDA growth | -51.3% | -37.6% | -13.3% | |
EBITDA margin | -3897.0% | -799.5% | -96.9% | -245.8% |
Depreciation | 0.7 | 0.6 | 0.4 | 0.1 |
EBITA | -12.4 | -24.6 | -38.8 | -44.4 |
EBITA margin | -4130.0% | -819.9% | -97.9% | -246.6% |
Amortization of intangibles | 39.3 | 27.9 | | |
EBIT [+] | -51.7 | -52.5 | -38.8 | -44.4 |
EBIT growth | -1.5% | 35.3% | -12.7% | |
EBIT margin | -17227.0% | -1749.3% | -97.9% | -246.6% |
Non-recurring items [+] | 3.6 | | | |
Asset impairment | 3.6 | | | |
Interest income | 0.2 | 0.5 | 0.5 | 2.1 |
Interest income | 0.2 | 0.5 | 0.5 | 2.1 |
Other income (expense), net [+] | 4.6 | 14.7 | -10.1 | |
Gain (loss) on derivative instruments | | | -13.8 | |
Change in fair value of warrants | 5.4 | 15.2 | | |
Pre-tax income | -50.6 | -37.3 | -48.4 | -42.4 |
Income taxes | 0.4 | 0.4 | 0.2 | 0.1 |
Net income | -50.9 | -37.6 | -62.4 | -58.4 |
Net margin | -16972.3% | -1254.5% | -157.5% | -324.1% |
|
Basic EPS [+] | ($0.96) | ($0.73) | ($3.30) | ($4.44) |
Growth | 31.9% | -77.8% | -25.7% | |
Diluted EPS [+] | ($0.96) | ($0.73) | ($3.30) | ($4.44) |
Growth | 32.7% | -77.9% | -25.7% | |
|
Shares outstanding (basic) [+] | 52.8 | 51.5 | 18.9 | 13.2 |
Growth | 2.5% | 171.9% | 43.8% | |
Shares outstanding (diluted) [+] | 52.8 | 51.8 | 18.9 | 13.2 |
Growth | 1.9% | 173.6% | 43.8% | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |